OMNEON
A Phase IIb, Randomized, Placebo-Controlled, Dose-Range Finding Clinical Trial to Study the Safety and Efficacy of MK-3102 in Patients With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control
- Stadium
- klaar
- Middel
- MK-3102
- Populatie
- Diabetes Mellitus
- Fase
- IIb
- First Patient In
- 1 januari 2012
- Last Patient In
- 31 december 2014
- Last Patient Last Visit
- -
Contact Bestuur
